by Brandon Tudor | Jun 23, 2026 | Blog
Summary: Microplastics May Worsen Fatty Liver Disease, New Study Suggests Researchers at the University of Oklahoma have found that microplastics may significantly worsen fatty liver disease, especially when combined with a high-fat, high-cholesterol diet. The...
by Brandon Tudor | Jun 13, 2026 | Blog
Summary: Quality of Life Remains Stable in Autoimmune Liver Disease (EMJ Hepatology, June 2026) The article reports on a longitudinal study of 252 patients with autoimmune liver diseases (AILD)—including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC),...
by Brandon Tudor | Jun 3, 2026 | Blog
The article, “A therapeutic turning point in metabolic liver disease” (npj Gut and Liver, June 2026), is an editorial that argues the field of metabolic liver disease has entered a new era, driven by clearer disease definitions, deeper mechanistic understanding, and...
by Brandon Tudor | May 28, 2026 | Blog
Roche announced a new “Liver Disease Panel,” which it says is the first certified suite of digital algorithms designed to help clinicians detect and manage chronic liver disease (CLD) earlier and more efficiently. Key points from the announcement: The panel focuses...
by Brandon Tudor | May 17, 2026 | Blog
This May 16, 2026 Cureus review titled “Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Diagnostic Pathways, Noninvasive Fibrosis Assessment, and Therapeutic Strategies” is essentially a “state of the field” overview of MASLD (formerly...
